ECG

MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker

Retrieved on: 
Monday, January 17, 2022 - 4:00am

CLAMART, France, Jan. 16,2022 /PRNewswire/ -- MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea.

Key Points: 
  • CLAMART, France, Jan. 16,2022 /PRNewswire/ -- MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea.
  • The devices are equipped with Bluetooth technology for streamlined remote monitoring when paired with MicroPort CRM's SmartView Connect home monitor, already approved in Japan.
  • Benot Clinchamps, President of MicroPort CRM, noted, "We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions.
  • MicroPort CRM is a pioneering company in the field of Cardiac Rhythm Management (CRM), and a subsidiary of MicroPort Scientific Corporation (stock code: 00853.HK), with world headquarters in Clamart, near Paris, France.

MobilDrTech Named US Distribution Partner for VoCare's Vitals360® Remote Monitoring Device

Retrieved on: 
Saturday, January 15, 2022 - 12:00pm

HOUSTON, Jan. 15, 2022 /PRNewswire-PRWeb/ -- Vitals360 is a revolutionary medical device, purpose-built from the ground up to be an optimal solution for remote patient monitoring and telehealth.

Key Points: 
  • HOUSTON, Jan. 15, 2022 /PRNewswire-PRWeb/ -- Vitals360 is a revolutionary medical device, purpose-built from the ground up to be an optimal solution for remote patient monitoring and telehealth.
  • Monitorable vitals for the Vitals360 include heart rate, blood pressure, blood oxygen saturation, ECG heart rhythms and temperature.
  • MobilDrTech is an experienced distribution partner who will speed the transition from hubs with multiple connected devices to a single self-contained platform."
  • VoCare, Inc., is an Indiana-based company that has developed the world's first professional grade hand-held medical monitoring device.

DGAP-News: G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations

Retrieved on: 
Friday, January 14, 2022 - 12:05pm

G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations

Key Points: 
  • G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations
    The issuer is solely responsible for the content of this announcement.
  • Dr. Yacov Geva, President and CEO of G Medical Innovations, and Michael McDade, CEO of McDade Products, LLC , announced today that they acquired an undisclosed number of shares of G Medical Innovations (NASDAQ: GMVD).
  • G Medical Tests and Services currently operates storefront testing locations in California.
  • During the next few months, the company expects to expand its network of storefront testing locations in California and other U.S. regions to be announced at a later date.

DGAP-News: McDade Products, LLC and G Medical Tests Secure Additional Purchase Order for $6.5 Million, Reflecting $3.5 Million Gross Margin, to be Delivered in Q1

Retrieved on: 
Wednesday, January 12, 2022 - 12:07pm

Secure Additional Purchase Order for $6.5 Million,

Key Points: 
  • Secure Additional Purchase Order for $6.5 Million,
    Reflecting $3.5 Million Gross Margin, to be Delivered in Q1
    The issuer is solely responsible for the content of this announcement.
  • PITTSBURGH, PA - McDade Products, LLC and G Medical Tests and Services, a division of G Medical Innovations Holdings Ltd. (NASDAQ: GMVD), today announced an additional $6.5 million purchase order for two million COVID-19 PCR collection test kits.
  • G Medical will be selling these units wholesale for $3.25 each, reflecting a gross profit of approximately $3.5 million.
  • G Medical Tests and Services is delighted to provide McDade with current and future purchase orders.

19Labs, QT Medical Launch Complete Telehealth Solutions With 12-Lead Resting ECG, Ultrasound, & More

Retrieved on: 
Tuesday, January 11, 2022 - 4:30pm

To address this problem, 19Labs and QT Medical announced acollaboration,to bring comprehensive, cost-effective, and intuitive eClinics worldwide.

Key Points: 
  • To address this problem, 19Labs and QT Medical announced acollaboration,to bring comprehensive, cost-effective, and intuitive eClinics worldwide.
  • PCA 500 is the only medical standard 12-lead resting ECG cleared by the FDA and CE Mark for professional as well as patient use.
  • "QT Medical has helped us in achieving our goal of solving remote healthcare," said Ram Fish, 19Labs CEO & Founder.
  • QT Medical is a visionary startup that aims to make hospital-grade 12-lead resting ECG accessible to everyone.

AliveCor Announces Strategic Additions to Executive Team

Retrieved on: 
Tuesday, January 11, 2022 - 2:00pm

Balsamo joins AliveCor from a Sequoia-backed stealth AI company, where he served as Chief Revenue Officer and interim Co-CEO.

Key Points: 
  • Balsamo joins AliveCor from a Sequoia-backed stealth AI company, where he served as Chief Revenue Officer and interim Co-CEO.
  • In that role, he oversaw commercial operations, managed strategic partnerships, helped close a $25 million strategic funding round, and oversaw a corporate restructuring.
  • Dr. Archana Dubey brings more than 25 years of experience as a physician, executive, entrepreneur, and strategic advisor to her role at AliveCor.
  • AliveCor is a privately-held company headquartered in Mountain View, Calif. "Consumer" or "Personal" ECGs are ECG devices available for direct sale to consumers.

iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update

Retrieved on: 
Monday, January 10, 2022 - 11:29pm

SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on the recent update by Novitas Solutions (Novitas), a Medicare Administrative Contractor (MAC), regarding updated rates applicable to the Current Procedural Terminology (CPT) codes 93243 and 93247.

Key Points: 
  • SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on the recent update by Novitas Solutions (Novitas), a Medicare Administrative Contractor (MAC), regarding updated rates applicable to the Current Procedural Terminology (CPT) codes 93243 and 93247.
  • On January 10, 2022, Novitas updated reimbursement rates for CPT codes 93243 and 93247 for the Houston jurisdiction to $223 and $233, respectively.
  • The updated rates demonstrate progress in further understanding costs associated with delivering the Zio service, said iRhythm CEO and President, Quentin Blackford.
  • iRhythm has analyzed the impact these updated 2022 Novitas rates would have had on full year 2021 revenue had those rates been in effect in 2021.

2021 Smartwatch Market Development and Leading Brands; Product Strategies in Healthcare Report - ResearchAndMarkets.com

Retrieved on: 
Monday, January 10, 2022 - 6:23pm

Development of the smartwatch market and includes global smartwatch shipment volume forecast for the period 2021-2025, touching on smartwatch market and brand positioning

Key Points: 
  • Development of the smartwatch market and includes global smartwatch shipment volume forecast for the period 2021-2025, touching on smartwatch market and brand positioning
    Trends in smartwatches used in healthcare applications from biometrics monitoring to specialized medical use, including five major functions of smartwatches in healthcare
    2.1.1 Heart Rate and Blood Oxygen: Detects Blood Volume and Concentration Changes with PPG; Heart Rate Monitoring is Mature due to Early Adoption
    2.1.2 Heart Rhythm: Collects ECG Signals and Draws ECGs Using Electric Shock Pads; Develops AI Capable of Interpreting Various Waveforms
    2.1.3 Pulse/Blood Pressure: Estimated from ECG and PPG Signals; Some Smartwatches Have Been Certified as Medical Products
    2.1.4 Stress and Sleep: Analyzes Activation of Nervous Systems via HRV; Leading Vendors Trying to Improve Accuracy by Detecting Sweat Secretion
    2.1.5 Blood Glucose: Non-Invasive Blood Glucose Measurement as Leading Smartwatch Vendors; Next Focus
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220110005901/en/

Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma

Retrieved on: 
Monday, January 10, 2022 - 1:00pm

The safety data of the last SAD cohort (300mg) and MAD cohort (200mg twice a day for 14 days) are pending.

Key Points: 
  • The safety data of the last SAD cohort (300mg) and MAD cohort (200mg twice a day for 14 days) are pending.
  • SACT-1s first in-human clinical trial is a Phase 1, Open-label Randomized, Single Cross Over Bioavailability and Food Effect Study of SACT-1 in healthy adult volunteers.
  • Aptorum is pleased to announce the successful completion of the trial, during which no SAE were observed.
  • This milestone supports the focus of Aptorum Group to embark on the exciting Phase II clinical trials for ALS-4 and planned Phase Ib/2a clinical trials for SACT-1, subject to IND clearance.

DGAP-News: McDade Products, LLC Joins Forces with G Medical Tests and Services to Provide U.S. Retailers with Millions of COVID-19 at-Home PCR Test Kits

Retrieved on: 
Monday, January 10, 2022 - 12:13pm

McDade Products is a division of McDade Group, a specialty sales, marketing, and distribution company serving the U.S. retail industry.

Key Points: 
  • McDade Products is a division of McDade Group, a specialty sales, marketing, and distribution company serving the U.S. retail industry.
  • McDade Products is now accepting orders for the co-branded LiveNow PCR Collection Kit, which will retail for $9.99.
  • The diagnostic PCR (polymerase chain reaction) test detects the presence or absence of SARS-CoV2, the virus that causes COVID-19.
  • On average, tests results are expected to be available online within 24 hours from the time the sample is received.